Antibiotic resistance: Why is it increasing in nursing homes?

Geriatrics

Volumn 52, Issue 7, 1997, Pages 34-44

  McCue, Jack D ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BERKSHIRE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL INFECTION; DRUG INDICATION; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NURSING HOME; ORAL DRUG ADMINISTRATION; PATIENT TRANSPORT; REVIEW;

AGED; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HOMES FOR THE AGED; HUMANS; INFECTION CONTROL; NURSING HOMES; RISK FACTORS;

EID: 0031394116     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Ouslander JG, Osterweil D, Morley J. Medical care in the nursing home. New York: McGraw-Hill, 1991:231-48.
2. Schicker JM, Franson TR, Duthie EH. Comparison of methods for calculation and depiction of incidence of infection rates in long-term care facilities. J Clin Epidemiol 1988; 41:757-61.
3. Alvarez S. Incidence and prevalence of nosocomial infectons in nursing homes. In: Verghese A, Berk SL (eds). Infections in nursing homes and long-term care facilities. Basel: Karger, 1990:41-54.
4. Katz PR, Beam TR Jr, Brand F, Boyce K. Antibiotic use in the nursing home. Physician practice patterns. Arch Intern Med 1990; 150:1465-8.
5. Flournoy DJ. Antimicrobial susceptibilities of bacteria from nursing home residents in Oklahoma. Gerontology 1994; 40:53-6.
6. Lee Y-L, Thrupp LD, Friis RH, et al. Nosocomial infection and antibiotic utilization in geriatric patients: A pilot prospective surveillance program in skilled nursing facilities. Gerontology 1992; 38:223-32.
7. Mulhausen PL, Harrell LJ, Weinberger M, et al. Contrasting methicillin-resistant Staphylococcus aureus in Veterans Affairs and community nursing homes. Am J Med 1996; 100:24-31.
8. Terpenning MS, Bradley SF, Wan JY, et al. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc 1994; 42:1062-9.
9. John JE, Ribner BS. Antibiotic resistance in long-term care facilities. Infect Control Hosp Epid 1991; 12:245-50.
10. Bradley SF, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: Colonization and infection in a long-term care facility. Ann Intern Med 1991; 115:417-22.
11. Valenti WM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged. N Engl J Med 1978: 1108-11.
12. Irwin RS, Whitaker S, Pratter MR, et al. The transiency of oropharyngeal colonization of gram-negative bacilli in residents of a skilled nursing facility. Chest 1982; 81:31-5.
13. Gardner ID. The effect of aging on susceptibility to infection. Rev Infect Dis 1980; 2:801-10.
14. Yoshikawa TT, Norman DC. Treatment of infections in elderly patients. Med Clin North Am 1995; 79:651-66.
15. Hsu CC, Masaluso CP, Special L, et al. High rate of methicillin-resistant Staphylococcus aureus isolated from nursing home patients. Arch Intern Med 1988; 148:567-70.
16. Boyce JM. Methicillin-resistant Staphylococcus aureus in nursing homes: Putting the problem in perspective. Infect Control Hosp Epidemiol 1991; 12:416-21.
17. Murphy S, Denman S, Bennett RG, et al. Methicillin-resistant Staphylococcus aureus colonization in a long-term facilitiy. J Am Geriatr Soc 1992; 40:213-7.
18. Gaynes RP, Weinstein RA, Chamberlin W, Kabins SA. Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med 1985; 145:1804-7.
19. Bjork DT, Pelletier LL, Tight RR. Urinary tact infections with antibiotic resistant organisms in catheterized nursing home patients. Infect Control 1984; 5:173-80.
20. Garabaldi RA, Brodine S, Matsumiya S. Infections among patients in nursing homes. N Engl J Med 1981; 305:731-5.
21. Dalhoff A. Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance. Infection 1994; 22(suppl 2):S111-21.
22. Bosso JA. Bacterial resistance to antibiotics: Mechanisms and prevalence in hospitals and nursing homes. DICP 1989; 23:556-61.
23. Katz PR. Antibiotics for nursing home residents. When are they appropriate? Postgrad Med 1993; 93:173-80.
24. Satterfield N. Infection control in long-term care facilities: The hospital-based practitioner's role. Infect Control Hosp Epidemiol 1993; 14:40-7.
25. Jones SR, Parker DF, Liebow ES, et al. Appropriateness of antibiotic therapy in long-term care facilities. Am J Med 1987; 83:499-502.
26. Mehr MR, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients. J Fam Pract 1992; 34:585-91.
27. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331:377-82.
28. McCue JD. Rationale for the use of oral fluoroquinolones as empiric treatment of nursing home infections. Arch Fam Med 1994; 3:157-64.
29. Acar JF, O'Brien TF, Goldstein FW, Jones RN. The epidemiology of bacterial resistance to quinolones. Drugs 1993; 45(suppl 3):24-8.
30. Coll PP, Crabtree BF, O'Connor PJ, Klenzak. Clinical risk factors for methicillin-resistant Staphylococcus aureus bacteriuria in a skilled-care nursing home. Arch Fam Med 1994; 3:357-60.
31. Budnick LD, Schaefler S. Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group. Am J Pub Health 1990; 80:810-3.
32. Bradley SF, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: Colonization and infection in a long-term care facility. Ann Intern Med 1991; 115:417-22.
33. Muder RR, Brennen C, Wagener MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114:107-12.
34. Thys JP, Jacobs F, Byl B. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia. Eur J Clin Microbiol Infec Dis 1991; 10:304-15.
35. Sanders WE, Morris JF, Alessi P, et al. Oral ofloxacin for the treatment of acute bacterial pneumonia. Use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial. Am J Med 1991; 91:261-6.
36. Lode H, Wiley E, Olshewski P, et al. Prospective randomized trials of new quinolones versus beta-lactam antibiotics in lower respiratory infections. Scand J Infec Dis 1990; 68(suppl):50-5.
37. Gentry LO. Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: A review. Clin Infect Dis 1992; 14:285-97.
38. Evans TG, Kamara A, Minnick K, et al. Pneumococcal resistance in southwest Virginia. Antimicrobial Agents Chemother 1995; 39:985-6.
39. Zinner SH, Mayer KH. Sulfonamides and trimethoprim. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone, 1995:354-64.
40. Physicians' Desk Reference. Montvale, NJ: Medical Economics Data Production Company, 1995:2028-9.
41. Armitage KB, Salata RA, Landefeld CS. Urosepsis in the elderly: Clinical and microbiologic characteristics. Infect Dis Clin Pract 1993; 2:260-6.
42. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329:1328-34.
43. Yoshikawa TT, Norman DC. Infection control in long-term care. Clin Geriatr Med 1995; 11:467-80.